DNMT3B (C46359T) polymorphisms and immunoexpression of DNMT3b and DNMT1 proteins in oral lichen planus

Pathobiology

Volumn 79, Issue 1, 2012, Pages 18-23

  Fonseca Silva, Thiago ^a   De Oliveira, Marcos Vinícius MacEdo ^a   Fraga, Carlos Alberto De Carvalho ^a   Farias, Lucyana Conceição ^a,b   Gomes, Érika Patrícia Pereira ^a   Barros, Lucas Oliveira ^a   Roy, Ashbeel ^c   Santiago Gomez, Ricardo ^b   De Paula, Alfredo Maurício Batista ^a   Guimarães, André Luiz Sena ^a  

^a STATE UNIVERSITY OF MONTES CLAROS   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c WESTERN UNIVERSITY   (Canada)

Author keywords

DNA methylation; DNMT3b polymorphism; Oral inflammatory fibrous hyperplasia; Oral lichen planus

Indexed keywords

CYTOSINE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; THYMINE;

ADULT; ARTICLE; CONTROLLED STUDY; DNMT 3B GENE; FEMALE; GENE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; LICHEN PLANUS; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; FEMALE; GENE FREQUENCY; HUMANS; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRESSOR PROTEINS; YOUNG ADULT;

EID: 84855874840     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000330171     Document Type: Article

References (48)

1. Anuradha C, Reddy BV, Nandan SR, Kumar SR: Oral lichen planus: a review. NY State Dent J 2008; 74:66-68.
2. Eisen D: The clinical manifestations and treatment of oral lichen planus. Dermatol Clin 2003; 21: 79-89. (Pubitemid 36255251)
3. Sousa FA, Rosa LE: Oral lichen planus: clini-cal and histopathological considerations. Braz J Otorhinolaryngol 2008; 74:284-292.
4. Mollaoglu N: Oral lichen planus: a review. Br J Oral Maxillofac Surg 2000; 38:370-377. (Pubitemid 30623946)
5. Perdigao PF, Guimaraes AL, Victoria JM, Xavier GM, Romano-Silva MA, Gomez RS: Serotonin transporter gene polymorphism (5-HTTLPR) in patients with oral lichen pla-nus. Arch Oral Biol 2007; 52:889-893. (Pubitemid 47125836)
6. Eisen D: The clinical features, malignant po-tential, and systemic associations of oral li-chen planus: a study of 723 patients. J Am Acad Dermatol 2002; 46: 207-214. (Pubitemid 34118376)
7. Jungell P: Oral lichen planus: a review. Int J Oral Maxillofac Surg 1991; 20:129-135.
8. Fang M, Zhang W, Chen Y, He Z: Malignant transformation of oral lichen planus: a retro-spective study of 23 cases. Quintessence Int 2009; 40: 235-242.
9. Szarka K, Tar I, Feher E, Gall T, Kis A, Toth ED, Boda R, Marton I, Gergely L: Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential. Oral Microbiol Immunol 2009; 24: 314-318.
10. Yarom N, Shani T, Amariglio N, Taicher S, Kaplan I, Vered M, Rechavi G, Trakhtenbrot L, Hirshberg A: Chromosomal numerical aberrations in oral lichen planus. J Dent Res 2009; 88: 427-432.
11. Epstein JB, Wan LS, Gorsky M, Zhang L: Oral lichen planus: progress in understand-ing its malignant potential and the implica-tions for clinical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96:32-37. (Pubitemid 37490758)
12. Gonzalez-Moles MA, Scully C, Gil-Montoya JA: Oral lichen planus: controversies sur-rounding malignant transformation. Oral Dis 2008; 14:229-243. (Pubitemid 351379716)
13. Lanfranchi-Tizeira HE, Aguas SC, Sano SM: Malignant transformation of atypical oral li-chen planus: a review of 32 cases. Med Oral 2003; 8:2-9. (Pubitemid 36150914)
14. Larsson A, Warfvinge G: Malignant trans-formation of oral lichen planus. Oral Oncol 2003; 39:630-631. (Pubitemid 36694489)
15. Mignogna MD, Fedele S, Lo Russo L, Mignogna C, de Rosa G, Porter SR: Field can-cerization in oral lichen planus. Eur J Surg Oncol 2007; 33:383-389. (Pubitemid 46508644)
16. Magnusson BC, Rasmusson LG: The giant cell fibroma: a review of 103 cases with im-munohistochemical findings. Acta Odontol Scand 1995; 53: 293-296.
17. Santos PP, Nonaka CF, Pinto LP, de Souza LB: Immunohistochemical expression of mast cell tryptase in giant cell fibroma and inflammatory fibrous hyperplasia of the oral mucosa. Arch Oral Biol 2011; 56: 231-237.
18. Guz J, Foksinski M, Olinski R: Mechanism of DNA methylation and demethylation - its role in control of genes expression (in Pol-ish). Postepy Biochem 2010; 56: 7-15.
19. Cao J, Zhou J, Gao Y, Gu L, Meng H, Liu H, Deng D: Methylation of p16 CpG island as-sociated with malignant progression of oral epithelial dysplasia: a prospective cohort study. Clin Cancer Res 2009; 15:5178-5183.
20. Ducasse M, Brown MA: Epigenetic aberra-tions and cancer. Mol Cancer 2006; 5:60.
21. Fazzari MJ, Greally JM: Epigenomics: be-yond CpG islands. Nat Rev Genet 2004; 5: 446-455.
22. Singal R, Ginder GD: DNA methylation. Blood 1999; 93: 4059-4070. (Pubitemid 29279247)
23. Bestor TH: The DNA methyltransferases of mammals. Hum Mol Genet 2000; 9: 2395-2402.
24. Girault I, Tozlu S, Lidereau R, Bieche I: Ex-pression analysis of DNA methyltransferases 1, 3a, and 3b in sporadic breast carcinomas. Clin Cancer Res 2003; 9: 4415-4422. (Pubitemid 37248399)
25. Farias LC, Fraga CA, De Oliveira MV, Silva TF, Marques-Silva L, Moreira PR, De-Paula AM, Gomez RS, Guimaraes AL: Effect of age on the association between p16CDKN2A methylation and DNMT3B polymorphism in head and neck carcinoma and patient sur-vival. Int J Oncol 2010; 37: 167-176.
26. Montgomery KG, Liu MC, Eccles DM, Campbell IG: The DNMT3B C→T promoter polymorphism and risk of breast cancer in a British population: a case-control study. Breast Cancer Res 2004; 6:R390-394.
27. Singal R, Das PM, Manoharan M, Reis IM, Schlesselman JJ: Polymorphisms in the DNA methyltransferase 3b gene and prostate can-cer risk. Oncol Rep 2005; 14: 569-573.
28. Parra FC, Amado RC, Lambertucci JR, Ro-cha J, Antunes CM, Pena SD: Color and ge-nomic ancestry in Brazilians. Proc Natl Acad Sci USA 2003; 100:177-182.
29. Scully C, Carrozzo M: Oral mucosal disease: lichen planus. Br J Oral Maxillofac Surg 2008; 46: 15-21. (Pubitemid 350266149)
30. Liu HW, Hu BQ, Cao CF: The p16 methyla-tion in oral leukoplakia and oral squamous cell carcinoma (in Chinese). Zhonghua Kou Qiang Yi Xue Za Zhi 2005; 40:94-97.
31. Su Y, Wang X, Zhu WG: DNA methyltrans-ferases: the role in regulation of gene expres-sion and biological processes (in Chinese). Yi Chuan 2009; 31:1087-1093.
32. Teodoridis JM, Strathdee G, Brown R: Epi-genetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker. Drug Resist Updat 2004; 7:267-278. (Pubitemid 39469099)
33. Baba S, Yamada Y, Hatano Y, Miyazaki Y Mori H, Shibata T, Hara A: Global DNA hy-pomethylation suppresses squamous carci-nogenesis in the tongue and esophagus. Can-cer Sci 2009; 100:1186-1191.
34. Mizuno S, Chijiwa T, Okamura T, Akashi K Fukumaki Y, Niho Y, Sasaki H: Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 2001; 97:1172-1179. (Pubitemid 32183737)
35. Robertson KD, Uzvolgyi E, Liang G, Tal-madge C, Sumegi J, Gonzales FA, Jones PA: The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overex-pression in tumors. Nucleic Acids Res 1999; 27:2291-2298. (Pubitemid 29245646)
36. Barish GD, Yu RT, Karunasiri M, Ocampo CB, Dixon J, Benner C, Dent AL, Tangirala RK, Evans RM: Bcl-6 and NF-kappaB cis-tromes mediate opposing regulation of the innate immune response. Genes Dev 2010; 24:2760-2765.
37. Januchowski R, Prokop J, Jagodzinski PP: Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythemato-sus. J Appl Genet 2004; 45: 237-248. (Pubitemid 38834576)
38. Guimaraes AL, Correia-Silva Jde F, Diniz MG, Xavier GM, Horta MC, Gomez RS: In-vestigation of functional gene polymor-phisms: IL-1B, IL-6 and TNFA in benign mi-gratory glossitis in Brazilian individuals. J Oral Pathol Med 2007; 36: 533-537. (Pubitemid 47393532)
39. Guimaraes AL, Correia-Silva Jde F, de Sá AR, Victoria JM, Diniz MG, Costa Fde O, Gomez RS: Investigation of functional gene poly-morphisms IL-1beta, IL-6, IL-10 and TNF-alpha in individuals with recurrent aphthous stomatitis. Arch Oral Biol 2007; 52:268-272. (Pubitemid 46110825)
40. Guimaraes AL, de Sá AR, Victoria JM, de Fatima Correia-Silva J, Gomez MV, Gomez RS: Interleukin-1beta and serotonin trans-porter gene polymorphisms in burning mouth syndrome patients. J Pain 2006; 7: 654-658. (Pubitemid 44291601)
41. Xavier GM, de Sá AR, Guimaraes AL, da Sil-va TA, Gomez RS: Investigation of function-al gene polymorphisms interleukin-1beta, interleukin-6, interleukin-10 and tumor ne-crosis factor in individuals with oral lichen planus. J Oral Pathol Med 2007; 36:476-481. (Pubitemid 47222103)
42. Dan H, Liu W, Zhou Y, Wang J, Chen Q, Zeng X: Association of interleukin-8 gene poly-morphisms and haplotypes with oral lichen planus in a Chinese population. Inflamma-tion 2010; 33:76-81.
43. Dutra WO, Moreira PR, Souza PE, Gollob KJ, Gomez RS: Implications of cytokine gene polymorphisms on the orchestration of the immune response: lessons learned from oral diseases. Cytokine Growth Factor Rev 2009; 20: 223-232.
44. Liu Z, Wang L, Wang LE, Sturgis EM, Wei Q: Polymorphisms of the DNMT3B gene and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett 2008; 268:158-165.
45. Cebrian A, Pharoah PD, Ahmed S, Ropero S, Fraga MF, Smith PL, Conroy D, Luben R, Perkins B, Easton DF, Dunning AM, Esteller M, Ponder BA: Genetic variants in epigenetic genes and breast cancer risk. Carcinogenesis 2006; 27:1661-1669. (Pubitemid 44303919)
46. Jones JS, Amos CI, Pande M, Gu X, Chen J, Campos IM, Wei Q, Rodriguez-Bigas M, Lynch PM, Frazier ML: DNMT3b polymor-phism and hereditary nonpolyposis colorec-tal cancer age of onset. Cancer Epidemiol Biomarkers Prev 2006; 15:886-891. (Pubitemid 43823513)
47. Simao Tde A, Simoes GL, Ribeiro FS, Cidade DA, Andreollo NA, Lopes LR, Macedo JM, Acatauassu R, Teixeira AM, Felzenszwalb I, Pinto LF, Albano RM: Lower expression of p14ARF and p16INK4a correlates with high-er DNMT3B expression in human oesopha-geal squamous cell carcinomas. Hum Exp Toxicol 2006; 25: 515-522. (Pubitemid 44409041)
48. Resende RG, Correia-Silva Jde F, Arao TC, Silva TA, Abreu MH, Bittencourt H, Gomez RS: Investigation of functional IL-10 gene polymorphism and IL-10 levels in acute graft-versus-host disease. J Clin Immunol 2010; 30:465-473.